Detalhe da pesquisa
1.
Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.
Catheter Cardiovasc Interv
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713843
2.
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
Catheter Cardiovasc Interv
; 102(2): 221-232, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232278
3.
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Cardiovasc Diabetol
; 20(1): 217, 2021 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717627
4.
Age dependency of plasma vitamin B12 status markers in Dutch children and adolescents.
Pediatr Res
; 90(5): 1058-1064, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33574561
5.
Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting.
Cardiovasc Interv Ther
; 39(2): 173-182, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353865
6.
Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
Atherosclerosis
; 392: 117488, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598970
7.
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents.
Eur Heart J Acute Cardiovasc Care
; 12(11): 774-781, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619976
8.
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention.
Front Cardiovasc Med
; 10: 1160201, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37745109
9.
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
Int J Cardiol
; 374: 27-32, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496036
10.
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials.
Cardiovasc Diagn Ther
; 13(4): 673-685, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675090
11.
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
Atherosclerosis
; 355: 52-59, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641327
12.
Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers.
J Am Heart Assoc
; 11(22): e026041, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346050
13.
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
Int J Cardiol
; 300: 93-98, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511193
14.
Galectin-4, a Negative Regulator of Oligodendrocyte Differentiation, Is Persistently Present in Axons and Microglia/Macrophages in Multiple Sclerosis Lesions.
J Neuropathol Exp Neurol
; 77(11): 1024-1038, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252090